DOCSLIB.ORG

Ayahuasca Characterization, Metabolism in Humans, And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ayahuasca Characterization, Metabolism in Humans, And Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2012 Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N- dimethyltryptamines Ethan Hamilton McIlhenny Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Medicine and Health Sciences Commons Recommended Citation McIlhenny, Ethan Hamilton, "Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N- dimethyltryptamines" (2012). LSU Doctoral Dissertations. 2049. https://digitalcommons.lsu.edu/gradschool_dissertations/2049 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. AYAHUASCA CHARACTERIZATION, METABOLISM IN HUMANS, AND RELEVANCE TO ENDOGENOUS N,N-DIMETHYLTRYPTAMINES A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and School of Veterinary Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Interdepartmental Program in Veterinary Medical Sciences through the Department of Comparative Biomedical Sciences by Ethan Hamilton McIlhenny B.A., Skidmore College, 2006 M.S., Tulane University, 2008 August 2012 Acknowledgments Infinite thanks, appreciation, and gratitude to my mother Bonnie, father Chaffe, brother Matthew, grandmothers Virginia and Beverly, and to all my extended family, friends, and loved ones. Without your support and the visionary guidance of my friend and advisor Dr. Steven Barker, none of this work would have been possible. Special thanks to Dr. Rick Strassman MD and the Cottonwood Research Foundation for helping me find and navigate this path. We acknowledge and are grateful for the collaborative research efforts and dedication of Dr. Jordi Riba and his lab which obtained the human urine and blood samples necessary for the included studies. We wish to dedicate this work to the memory of our friend and colleague, Dr. Manel J. Barbanoj. We acknowledge Dr. Leanna Standish for her diligent work in bringing ayahuasca towards clinical trials and collaborative efforts in supplying our lab with ayahuasca samples. We thank Dr. Dave E. Nichols, Dr. Laurent Micouin and Dr. Simon D. Brandt for generously providing analytical compounds. We thank Connie David, Izabela Lomnicka, Pam Waller and Marian Waguespack for technical support in lab. I thank my dissertation committee members Dr. George Strain, Dr. Arthur Penn, Dr. Joseph Francis, and Dr. Samuel Gilman. I thank the Louisiana State Board of Regents for the generous fellowship grant support they provided. I thank Dr. Luis Eduardo Luna, Dr. Dennis McKenna, Dr. Michael Winkelman and Dr. Ede Frecska MD for opportunity, friendship, and insights. I thank and acknowledge the plant teachers Ayahuasca and Chacruna for wisdom, teachings and healing. I express my eternal and infitie gratitude to the form and formless, to the water, earth, air, and fire for our feelings, sensations, thoughts, intuition, and intentionality, to the central source within and mysterious truth that surrounds, to the one shared unity and the many reflections of it. -Blessings, gratitude, love and light to all beings and all becomings in all places and all times. ii Table of Contents Acknowledgments .........................................................................................................................ii List of Tables..................................................................................................................................vi List of Figures................................................................................................................................vii Abstract.........................................................................................................................................viii Chapter 1. Introduction ..................................................................................................................1 1.1 Semanitcs……………………………………………………………………….…….1 1.2 Historical and Social Context…………………………………………………….…..3 1.3 Ayahuasca……………………………………………………………………….……7 1.4 Chapter Contents……………………………………………………………………..9 1.5 References……………………………………………………………………………15 Chapter 2. Direct Analysis of Psychoactive Tryptamine and Harmala Alkaloids in the Amazonian Botanical Medicine Ayahuasca by Liquid Chromatography-Electrospray Ionization-Tandem MassSpectrometry………………………………………..............................21 2.1 Introduction……………………………………………………………………………....…22 2.2 Materials and Methods………………………………………………………………..25 2.2.1 Reagents and Chemicals…………………………………………………...25 2.2.2 Botanical Raw Material and Ayahuasca……………………………….…..25 2.2.3 Preparation of standards and samples for analysis………………………...26 2.2.4 LC-ESI-MS/MS analysis…………………………………………………..27 2.2.5 Calculations………………………………………………………………..28 2.3 Results……………………………………………………………………………….28 2.3.1 Validation of the Method………………………………………………….28 2.3.2 Characterization of ayahuasca preparations……………………………….34 2.4 Discussion……………………………………………………………………...……35 2.5 Conclusions………………………………………………………………...………..38 2.6 References……………………………………………………………………...……39 Chapter 3. Methodology for and the Determination of the Major Constituents and Metabolites of the Amazonian Botanical Medicine Ayahuasca in Human Urine…………..….42 3.1 Introduction………………………………………………………………….….…43 3.2 Experimental………………………………………………………………….….…45 3.2.1 Solvents and Standards……………………………………………..…….45 3.2.2 Preparation of Urine Samples……………………………………….……47 3.2.3 Freeze Dried Ayahuasca Administration and Urine Collection…….……48 3.2.4 Enzyme Hydrolysis………………………………………………….……48 3.2.5 Determination of Matrix Effects…………………………………………49 3.2.6 LC-ESI-MS/MS analysis…………………………………………………49 3.2.7 Determination of Inter- and Intra-assay Variation……………………….50 3.2.8 Calculations………………………………………………………………51 3.3 Results and Discussion……………………………………………………………..52 3.3.1 Evaluation of the Method…………………………………………….…..52 3.3.2 Matrix Effects……………………………………………………....……60 iii 3.3.3 Major Constituents and Metabolites of Ayahuasca in Urine………….….60 3.4 References……………………………………………………………………….….67 Chapter 4. Methodology for Determining Major Constituents of Ayahuasca and Their Metabolites in Blood…………………………………………………………………………...73 4.1 Introduction…………………………………………………………………….…..74 4.2 Experimental…………………………………………………………………….….76 4.2.1 Standards and reagents…………………………………………………...76 4.2.2 Freeze Dried Ayahuasca Administration and Plasma Collection………...78 4.2.3 Sample preparation……………………………………………………….79 4.2.4 Determination of Matrix Effects…………………………………………80 4.2.5 Enzyme Hydrolysis……………………………………………………….80 4.2.6 LC-HESI-MS/MS analysis……………………………………………….81 4.2.7 Calculations………………………………………………………………84 4.3 Results and Discussion……………………………………………………………..85 4.3.1 Method Performance……………………………………………………..85 4.3.2 Matrix Effects……………………………………………………………92 4.3.3 Analysis of Administration Samples……………………………………..94 4.4 Conclusions………………………………………………………………………...96 4.5 References………………………………………………………………………….96 Chapter 5. Summary and Conclusions……………………………………………………...….100 5.1 Summary and Conclusions……………………………………………………..…..100 Appendix A: Cross-Cultural Variations in Psychoactive Alkaloid Content in Ayahuasca Teas Used in Spiritual Ceremonies……………………………………………………………108 A.1 Introduction………………………………………………………………...……110 A.2 Materials and methods……………………………………………………....……111 A.2.1 Materials……………………………………………………………...…111 A.2.2 Methods…………………………………………………………………111 A.3 Results……………………………………………………………………….…....113 A.3.1 DMT and 5-OH-DMT concentrations in ayahuasca teas……………….113 A.3.2 DMT, harmine, THH and harmol concentrations…………………...…..114 A.3.3 Beta-carboline alkaloid concentrations in ayahuasca teas……………....115 A.3.4 Bivariate and multivariate relationships among ayahuasca alkaloids…...116 A.4 Discussion…………………………………………………………………………120 A.5 Conclusions…………………………………………………………………..……121 A.6 Future Ayahuasca Characterization Publications……………………………...…..121 A.7 Future Publications to Prepare Ayahuasca for Clinical Trials…………………......122 A.8 References……………………………………………………………………….…123 Appendix B: Metabolism and Disposition of N,N-Dimethyltryptamine and Harmala Alkaloids After Oral Administration of Ayahuasca……………………………………………125 B.1 Introduction………………………………………………………………………...127 B.2 Materials and Methods……………………………………………………………..131 iv B.2.1 Volunteers…………………………………………………………....…..131 B.2.2 Drugs……………………………………………………………..…..…..132 B.2.3 Study Design and Sample Collection…………………………….…...….132 B.2.4 Analytical Method…………………………………………………...…..133 B.2.5 Statistics…………………………………………………………..…..….134 B.3 Results and Discussion……………………………………………………….….…139 B.4 Conclusion………………………………………………………..………..…..…..146 B.5 References………………………………………………………………..…..……146 Appendix C: A Critical Review of Reports of Endogenous Psychedelic N, N-Dimethyltryptamines in Humans: 1955-2010………………………………………....….150 C.1 Introduction………………………………………………………………….…..…152 C.2 Historical Perspective………………………………………………………..…..…155 C.3 Study Review……………………………………………………………………....168 C.3.1 HDMT: urine…………………………………………………………..…168 C.3.2 HDMT: blood…………………………………………………………….169 C.3.3 HDMT: cerebrospinal fluid………………………………………………170 C.3.4 DMT: urine……………………………………………………………….170 C.3.5
Load more

Recommended publications
  • The Therapeutic Potential of Ayahuasca 7 Michael A
    The Therapeutic Potential of Ayahuasca 7 Michael A. Coe and Dennis J. McKenna 7.1 Introduction Ayahuasca is a Quechua term that is commonly translated into “vine of the spirits, vine of the soul, or vine of the dead” and refers to jungle liana in the Malpighiaceae family taxonomically known as Banisteriopsiscaapi Spruce ex. Griseb. The same term is synonymous with a psychoactive tea or beverage traditionally used by cul- tural groups throughout parts of Brazil, Peru, Colombia, Bolivia, Venezuela, and Ecuador during rites of passage, divination, warfare, magico-religious practices, and for healing in the context of ethnomedical practices [1 – 4 ]. Traditional prepara- tions of ayahuasca tea include the combination of bark and stems of the Banisteriopsis caapi liana plus admixture plants; most commonly the leaves of Psychotria viridis Ruiz & Pav. (Rubiaceae) or Diplopterys cabrerana (Cuatrec.) B. Gates (Malpighiaceae) are boiled and reduced for several hours [5 ]. 7.1.1 Constituents Bioactive investigations of ayahuasca have revealed a unique synergistic chemistry and pharmacology in regard to its source and admixture plants. The leaves of P. viridis and D. cabrerana contain a highly potent, typically short-acting M. A. Coe , PhD (*) Department of Botany , University of Hawai`i at MƗnoa , 3190 Maile Way, St. John, Room 101 , 96822 Honolulu , HI , USA e-mail: [email protected] D. J. McKenna , PhD Center for Spirituality & Healing , University of Minnesota, Academic Health Center , Mayo Mail Code 505, 420 Delaware St. , Minneapolis , MN 55455 , USA e-mail: [email protected] © Springer International Publishing Switzerland 2017 123 D. Camfi eld et al. (eds.), Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders, DOI 10.1007/978-3-319-42307-4_7 124 M.A.
    [Show full text]
  • Summary of Product Characteristics
    Package leaflet: Information for the patient Fluoxetine 20mg Capsules, hard fluoxetine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. •If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. What is in this leaflet 1. What Fluoxetine is and what it is used for 2. What you need to know before you take Fluoxetine 3. How to take Fluoxetine 4. Possible side effects 5. How to store Fluoxetine 6. Contents of the pack and other information 1. What Fluoxetine is and what it is used for The name of your medicine is Fluoxetine 20mg Capsules, hard. It contains the active substance fluoxetine. Fluoxetine belongs to a group of medicines called selective serotonin reuptake inhibitor (SSRI) antidepressants. Fluoxetine can be given to treat the following conditions: Adults: • Major depressive episodes • The symptoms of a condition called obsessive-compulsive disorder (OCD). • The eating disorder bulimia nervosa. This medicine is used alongside psychotherapy for the reduction of binge-eating and purging. Children and adolescents aged 8 years and above: • Moderate to severe major depressive disorder, if the depression does not respond to psychological therapy after 4-6 sessions. Fluoxetine should be offered to a child or young person with moderate to severe major depressive disorder only in combination with psychological therapy.
    [Show full text]
  • Ayahuasca: Spiritual Pharmacology & Drug Interactions
    Ayahuasca: Spiritual Pharmacology & Drug Interactions BENJAMIN MALCOLM, PHARMD, MPH [email protected] MARCH 28 TH 2017 AWARE PROJECT Can Science be Spiritual? “Science is not only compatible with spirituality; it is a profound source of spirituality. When we recognize our place in an immensity of light years and in the passage of ages, when we grasp the intricacy, beauty and subtlety of life, then that soaring feeling, that sense of elation and humility combined, is surely spiritual. The notion that science and spirituality are somehow mutually exclusive does a disservice to both.” – Carl Sagan Disclosures & Disclaimers No conflicts of interest to disclose – I don’t get paid by pharma and have no potential to profit directly from ayahuasca This presentation is for information purposes only, none of the information presented should be used in replacement of medical advice or be considered medical advice This presentation is not an endorsement of illicit activity Presentation Outline & Objectives Describe what is known regarding ayahuasca’s pharmacology Outline adverse food and drug combinations with ayahuasca as well as strategies for risk management Provide an overview of spiritual pharmacology and current clinical data supporting potential of ayahuasca for treatment of mental illness Pharmacology Terms Drug ◦ Term used synonymously with substance or medicine in this presentation and in pharmacology ◦ No offense intended if I call your medicine or madre a drug! Bioavailability ◦ The amount of a drug that enters the body and is able to have an active effect ◦ Route specific: bioavailability is different between oral, intranasal, inhalation (smoked), and injected routes of administration (IV, IM, SC) Half-life (T ½) ◦ The amount of time it takes the body to metabolize/eliminate 50% of a drug ◦ E.g.
    [Show full text]
  • Malpighiaceae De Colombia: Patrones De Distribución, Riqueza, Endemismo Y Diversidad Filogenética
    DARWINIANA, nueva serie 9(1): 39-54. 2021 Versión de registro, efectivamente publicada el 16 de marzo de 2021 DOI: 10.14522/darwiniana.2021.91.923 ISSN 0011-6793 impresa - ISSN 1850-1699 en línea MALPIGHIACEAE DE COLOMBIA: PATRONES DE DISTRIBUCIÓN, RIQUEZA, ENDEMISMO Y DIVERSIDAD FILOGENÉTICA Diego Giraldo-Cañas ID Herbario Nacional Colombiano (COL), Instituto de Ciencias Naturales, Universidad Nacional de Colombia, Bogotá D. C., Colombia; [email protected] (autor corresponsal). Abstract. Giraldo-Cañas, D. 2021. Malpighiaceae from Colombia: Patterns of distribution, richness, endemism, and phylogenetic diversity. Darwiniana, nueva serie 9(1): 39-54. Malpighiaceae constitutes a family of 77 genera and ca. 1300 species, distributed in tropical and subtropical regions of both hemispheres. They are mainly diversified in the American continent and distributed in a wide range of habitats and altitudinal gradients. For this reason, this family can be a model plant group to ecological and biogeographical analyses, as well as evolutive studies. In this context, an analysis of distribution, richness, endemism and phylogenetic diversity of Malpighiaceae in natural regions and their altitudinal gradients was undertaken. Malpighiaceae are represented in Colombia by 34 genera and 246 species (19.1% of endemism). Thus, Colombia and Brazil (44 genera, 584 species, 61% of endemism) are the two richest countries on species of this family. The highest species richness and endemism in Colombia is found in the lowlands (0-500 m a.s.l.: 212 species, 28 endemics); only ten species are distributed on highlands (2500-3200 m a.s.l.). Of the Malpighiaceae species in Colombia, Heteropterys leona and Stigmaphyllon bannisterioides have a disjunct amphi-Atlantic distribution, and six other species show intra-American disjunctions.
    [Show full text]
  • 5-Meo-DMT) in a Journal of Psychedelic Studies Naturalistic Setting
    A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N- dimethyltryptamine (5-MeO-DMT) in a Journal of Psychedelic Studies naturalistic setting 4 (2020) 2, 104–113 1p 2 DOI: MALIN V. UTHAUG , R. LANCELOTTA , 3 4,5 10.1556/2054.2020.00123 A. M. ORTIZ BERNAL , A. K. DAVIS and p © 2020 The Author(s) JOHANNES G. RAMAEKERS1 1 Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, The Netherlands 2 ORIGINAL ARTICLE Innate Path, Lakewood, CO, USA 3 School of Human Ecology, Human Development and Family Studies, University of Wisconsin, Madison, WI, USA 4 College of Social Work, The Ohio State University, Columbus, 43210, OH, USA 5 Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, 21224, MD, USA Received: November 18, 2019 • Accepted: December 22, 2019 Published online: March 26, 2020 ABSTRACT Background: Previous research suggests a therapeutic potential of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). However, online anecdotal reports have described a phenomenon following cessation of the acute effects of 5-MeO-DMT use which has been termed reactivation (i.e., re-experiencing [“flashback”]). To date, no research has investigated whether different routes of administration may confer different reactivation rates, effects and experiences. Aims: We aimed to assess whether intramuscular injection (IM) and vaporization of 5-MeO-DMT conferred different reactivation rates, changes in satisfaction with life as well as ratings of the experience with ego dissolution and the mystical. Methods: Using internet-based advertisements, 27 respondents (Mage = 32.
    [Show full text]
  • Ayahuasca: Spirit Vine the Word “Ayahuasca” Refers to a Medicinal Brew with the Main Ingredient Being the Ayahuasca Vine (Banisteriopsis Caapi)
    Ayahuasca: Spirit Vine The word “Ayahuasca” refers to a medicinal brew with the main ingredient being the ayahuasca vine (banisteriopsis caapi). The vine is cooked, usually in combination with at least one other admixture plant, to produce a brown liquid that is consumed in healing ceremonies led by Amazon healers, called ayahuasqueros (curanderos). The effects of the brew vary greatly depending on which admixture plants are used in its preparation, how the curandero runs the healing ceremony, and a number of more complex aspects that are a bit of a mystery. Over 90 different indigenous tribes in the Amazon Rainforest have developed healing traditions based on the use of ayahuasca. This number becomes even more impressive when one considers the fact that many of these tribes live thousands of miles apart and would appear to have never had contact with each other. Within the philosophy of each tribe, one point remains consistent, which is that they originally learned about ayahuasca and the science of plant medicine from the plants themselves. The admixture plants most often used are the leaves of chacruna (Psychotria viridis) and yagé; also known as chaliponga, chagraponga, and huambisa (Diplopterys cabrerana). Ayahuasca is known and used throughout Perú, Ecuador, Colombia, Bolivia, and western Brazil. The use of ayahuasca is rapidly gaining awareness and acceptance throughout the world thanks to retreat programs and organized religious movements such as Santo Daime and the União do Vegetal (UDV), who won a supreme court decision for the right of members to use the sacred medicine in ceremonies in the United States.
    [Show full text]
  • Long-Lasting Analgesic Effect of the Psychedelic Drug Changa: a Case Report
    CASE REPORT Journal of Psychedelic Studies 3(1), pp. 7–13 (2019) DOI: 10.1556/2054.2019.001 First published online February 12, 2019 Long-lasting analgesic effect of the psychedelic drug changa: A case report GENÍS ONA1* and SEBASTIÁN TRONCOSO2 1Department of Anthropology, Philosophy and Social Work, Universitat Rovira i Virgili, Tarragona, Spain 2Independent Researcher (Received: August 23, 2018; accepted: January 8, 2019) Background and aims: Pain is the most prevalent symptom of a health condition, and it is inappropriately treated in many cases. Here, we present a case report in which we observe a long-lasting analgesic effect produced by changa,a psychedelic drug that contains the psychoactive N,N-dimethyltryptamine and ground seeds of Peganum harmala, which are rich in β-carbolines. Methods: We describe the case and offer a brief review of supportive findings. Results: A long-lasting analgesic effect after the use of changa was reported. Possible analgesic mechanisms are discussed. We suggest that both pharmacological and non-pharmacological factors could be involved. Conclusion: These findings offer preliminary evidence of the analgesic effect of changa, but due to its complex pharmacological actions, involving many neurotransmitter systems, further research is needed in order to establish the specific mechanisms at work. Keywords: analgesic, pain, psychedelic, psychoactive, DMT, β-carboline alkaloids INTRODUCTION effects of ayahuasca usually last between 3 and 5 hr (McKenna & Riba, 2015), but the effects of smoked changa – The treatment of pain is one of the most significant chal- last about 15 30 min (Ott, 1994). lenges in the history of medicine. At present, there are still many challenges that hamper pain’s appropriate treatment, as recently stated by American Pain Society (Gereau et al., CASE DESCRIPTION 2014).
    [Show full text]
  • Melatonin and Structurally-Related Compounds Protect Synaptosomal Membranes from Free Radical Damage
    Int. J. Mol. Sci. 2010, 11, 312-328; doi:10.3390/ijms11010312 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Melatonin and Structurally-Related Compounds Protect Synaptosomal Membranes from Free Radical Damage Sergio Millán-Plano 1, Eduardo Piedrafita 1, Francisco J. Miana-Mena 1, Lorena Fuentes-Broto 1, Enrique Martínez-Ballarín 1, Laura López-Pingarrón 2, María A. Sáenz 1 and Joaquín J. García 1,* 1 Department of Pharmacology and Physiology, Faculty of Medicine, University of Zaragoza, C/Domingo Miral s/n, 50009, Zaragoza, Spain; E-Mails: [email protected] (S.M.-P.); [email protected] (E.P.); [email protected] (F.J.M.-M.); [email protected] (L.F.-B.); [email protected] (E.M.-B.); [email protected] (M.A.S.) 2 Department of Human Anatomy and Histology, Faculty of Medicine, University of Zaragoza, C/Domingo Miral s/n, 50009, Zaragoza, Spain; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: 34-976-761-681; Fax: 34-976-761-700. Received: 23 December 2009 / Accepted: 15 January 2010 / Published: 21 January 2010 Abstract: Since biological membranes are composed of lipids and proteins we tested the in vitro antioxidant properties of several indoleamines from the tryptophan metabolic pathway in the pineal gland against oxidative damage to lipids and proteins of synaptosomes isolated from the rat brain. Free radicals were generated by incubation with 0.1 mM FeCl3, and 0.1 mM ascorbic acid. Levels of malondialdehyde (MDA) plus 4-hydroxyalkenal (4-HDA), and carbonyl content in the proteins were measured as indices of oxidative damage to lipids and proteins, respectively.
    [Show full text]
  • Designing Inhibitors Via Molecular Modelling Methods for Monoamine Oxidase Isozymes a and B Filiz Varnali Kadir Has Universit
    DESIGNING INHIBITORS VIA MOLECULAR MODELLING METHODS FOR MONOAMINE OXIDASE ISOZYMES A AND B FİLİZ VARNALI KADİR HAS UNIVERSITY 2012 DESIGNING INHIBITORS VIA MOLECULAR MODELLING METHODS FOR MONOAMINE OXIDASE ISOZYMES A AND B FİLİZ VARNALI M.S. in Computational Biology and Bioinformatics, Kadir Has University, 2012 Submitted to the Graduate School of Science and Engineering in partial fulfilment of the requirements for the degree of Master of Science in Computational Biology and Bioinformatics KADİR HAS UNIVERSITY 2012 DESIGNING INHIBITORS VIA MOLECULAR MODELING METHODS FOR MONOAMINE OXIDASE ISOZYMES A AND B Abstract In drug development studies, a large number of new drug candidates (leads) have to be synthesized and optimized by changing several moieties of the leads in order to increase efficacies and decrease toxicities. Each synthesis of these new drug candidates include multi-steps procedures. Overall, discovering a new drug is a very time-consuming and very costly works. The development of molecular modelling programs and their applications in pharmaceutical research have been formalized as a field of study known computer assisted drug design (CADD) or computer assisted molecular design (CAMD). In this study, using the above techniques, Monoamine Oxidase isozymes, which play an essential role in the oxidative deamination of the biogenic amines, were studied. Compounds that inhibit these isozymes were shown to have therapeutic value in a variety of conditions including several psychiatric and neurological as well as neurodegenerative diseases. First, a series of new pyrazoline derivatives were screened using molecular modelling and docking methods and promising lead compounds were selected, and proposed for synthesis as novel selective MAO-A or –B inhibitors.
    [Show full text]
  • Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion and Pharmacokinetics
    TESI DOCTORAL HUMAN PHARMACOLOGY OF AYAHUASCA JORDI RIBA Barcelona, 2003 Director de la Tesi: DR. MANEL JOSEP BARBANOJ RODRÍGUEZ A la Núria, el Marc i l’Emma. No pasaremos en silencio una de las cosas que á nuestro modo de ver llamará la atención... toman un bejuco llamado Ayahuasca (bejuco de muerto ó almas) del cual hacen un lijero cocimiento...esta bebida es narcótica, como debe suponerse, i á pocos momentos empieza a producir los mas raros fenómenos...Yo, por mí, sé decir que cuando he tomado el Ayahuasca he sentido rodeos de cabeza, luego un viaje aéreo en el que recuerdo percibia las prespectivas mas deliciosas, grandes ciudades, elevadas torres, hermosos parques i otros objetos bellísimos; luego me figuraba abandonado en un bosque i acometido de algunas fieras, de las que me defendia; en seguida tenia sensación fuerte de sueño del cual recordaba con dolor i pesadez de cabeza, i algunas veces mal estar general. Manuel Villavicencio Geografía de la República del Ecuador (1858) Das, was den Indianer den “Aya-huasca-Trank” lieben macht, sind, abgesehen von den Traumgesichten, die auf sein persönliches Glück Bezug habenden Bilder, die sein inneres Auge während des narkotischen Zustandes schaut. Louis Lewin Phantastica (1927) Agraïments La present tesi doctoral constitueix la fase final d’una idea nascuda ara fa gairebé nou anys. El fet que aquest treball sobre la farmacologia humana de l’ayahuasca hagi estat una realitat es deu fonamentalment al suport constant del seu director, el Manel Barbanoj. Voldria expressar-li la meva gratitud pel seu recolzament entusiàstic d’aquest projecte, molt allunyat, per la natura del fàrmac objecte d’estudi, dels que fins al moment s’havien dut a terme a l’Àrea d’Investigació Farmacològica de l’Hospital de Sant Pau.
    [Show full text]
  • (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
    pharmaceuticals Review Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact Andreia Machado Brito-da-Costa 1 , Diana Dias-da-Silva 1,2,* , Nelson G. M. Gomes 1,3 , Ricardo Jorge Dinis-Oliveira 1,2,4,* and Áurea Madureira-Carvalho 1,3 1 Department of Sciences, IINFACTS-Institute of Research and Advanced Training in Health Sciences and Technologies, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal; [email protected] (A.M.B.-d.-C.); ngomes@ff.up.pt (N.G.M.G.); [email protected] (Á.M.-C.) 2 UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 3 LAQV-REQUIMTE, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 4 Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal * Correspondence: [email protected] (D.D.-d.-S.); [email protected] (R.J.D.-O.); Tel.: +351-224-157-216 (R.J.D.-O.) Received: 21 September 2020; Accepted: 20 October 2020; Published: 23 October 2020 Abstract: Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical surveys still indicate its spiritual and medicinal uses, consumption of ayahuasca has been progressively related with a recreational purpose, particularly in Western societies. The ayahuasca aqueous concoction is typically prepared from the leaves of the N,N-dimethyltryptamine (DMT)-containing Psychotria viridis, and the stem and bark of Banisteriopsis caapi, the plant source of harmala alkaloids.
    [Show full text]
  • Nialamide; SOCIETIES and LECTURES CORRECTION
    414 BRITISH MEDICAL JOURNAL 15 MAY 1971 care, and administration of health services. A. Clements, P. A. Connell, Patricia A. Crawford, G. A. Cupper, M. R. Dean, L. L. Dom- "It is, in short, medicine applied to a group SOCIETIES AND LECTURES bey, D. P. De Bono, J. P. Delamere, Gil- than to an individual patient." The lean P. Duncan, D. B. Dunger, C. E. G. Farqu- rather Br Med J: first published as 10.1136/bmj.2.5758.414 on 15 May 1971. Downloaded from statement adds that it is hoped that the pro- For attending lectures marked * a fee is charged or harson, Pamela C. Fenney, Daphne C. Fielding, a ticket is required. Applications should be made I. R. Fletcher, M. S. Fletcher, Po-Kai Fok, G. J. visional Faculty will be in a position to re- Frost, R. M. Galbraith, Elizabeth A. S. Galvin, first to the institution concerned. D. J. Giraldi, Jenifer I. Glover, B. A. Greenway, ceive applications from those wishing to be- Mary Griffin, J. F. Hamlyn, M. H. Hampton, come founder members later in the year. Monday, 17 May G. P. Harris, P. B. Harvey, A. C. Hillyard, Gillian M. M. Hodge, N. Holmes, Sheilagh M. Further announcements will be made. ABERDEEN UNIVERSITY.-At Medical Buildings, Hope, C. C. Hugh, Joanna E. Ide, Alison Ironside, Foresterhill, 5.30 p.m., dentj centennial lecture Keatley E. James, W. J. Jarrett, Celia A. Jenkins, by Sir Robert Bradlaw: Pigmentation. J. R. Jenner, P. D. Jones, C. L. Kennedy, N. D. Monoamine-oxidase Inhibitors INSTITUTE OF DERMATOLOGY.-4.30 p.m., Mr.
    [Show full text]